Literature DB >> 20052447

Drug use and dosing in chronic kidney disease.

Yahaya Hassan1, Rowa'J Al-Ramahi, Noorizan Abd Aziz, Rozina Ghazali.   

Abstract

One of the most important drug-related problems in patients with chronic kidney disease (CKD) is medication dosing errors. Many medications and their metabolites are eliminated through the kidney. Thus, adequate renal function is important to avoid toxicity. Patients with renal impairment often have alterations in their pharmacokinetic and pharmacodynamic parameters. The clearance of drugs eliminated primarily by renal filtration is decreased by renal disease. Therefore, special consideration should be taken when these drugs are prescribed to patients with impaired renal function. Despite the importance of dosage adjustment in patients with CKD, such adjustments are sometimes ignored. Physicians and pharmacists can work together to accomplish safe drug prescribing. This task can be complex and require a stepwise approach to ensure effectiveness, minimise further damage and prevent drug nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20052447

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  19 in total

Review 1.  Computerized decision support systems: improving patient safety in nephrology.

Authors:  Jamison Chang; Claudio Ronco; Mitchell H Rosner
Journal:  Nat Rev Nephrol       Date:  2011-04-19       Impact factor: 28.314

2.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Authors:  Alex Secora; G Caleb Alexander; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

3.  Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Authors:  Solène M Laville; Marie Metzger; Bénédicte Stengel; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Carole Ayav; Elodie Speyer; Bruce M Robinson; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2018-09-24       Impact factor: 4.335

4.  Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.

Authors:  Janelle Guirguis-Blake; Gina A Keppel; John Holmes; Rex W Force; William Kriegsman; Laura-Mae Baldwin
Journal:  Fam Pract       Date:  2018-09-18       Impact factor: 2.267

Review 5.  Estimating renal function to reduce the risk of adverse drug reactions.

Authors:  Andrea Corsonello; Graziano Onder; Silvia Bustacchini; Mauro Provinciali; Sabrina Garasto; Pietro Gareri; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

6.  Drug-drug interactions and acute kidney injury: caveat prescriptor.

Authors:  Mallika L Mendu; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2014-05-10       Impact factor: 8.860

7.  Adverse Drug Reactions in Patients with CKD.

Authors:  Solène M Laville; Valérie Gras-Champel; Julien Moragny; Marie Metzger; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Bruce M Robinson; Bénédicte Stengel; Ziad A Massy; Sophie Liabeuf
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-01       Impact factor: 8.237

8.  Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

Authors:  Marc Evans; Sylvie Dejager; Anja Schweizer; James E Foley
Journal:  Diabetes Ther       Date:  2015-03-18       Impact factor: 2.945

9.  Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.

Authors:  Hasniza Zaman Huri; Hoo Fun Wee
Journal:  BMC Endocr Disord       Date:  2013-01-07       Impact factor: 2.763

10.  Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study.

Authors:  M Angeles Via-Sosa; Natali Lopes; Marian March
Journal:  BMC Fam Pract       Date:  2013-07-13       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.